S&P 500   3,585.62
DOW   28,725.51
QQQ   267.26
Want to Increase Your Conversion Rates? This Is the Biggest Threat to Your Success.
Market Wizard who made $95 million for his clients in 2008 – and predicted the 2022 collapse back in January – reveals his strategy: (Ad)pixel
Russia accused of 'kidnapping' head of Ukraine nuclear plant
EU chief: New Greece-Bulgaria gas pipeline 'means freedom'
Market Wizard who made $95 million for his clients in 2008 – and predicted the 2022 collapse back in January – reveals his strategy: (Ad)pixel
Danish Energy Agency says Nord Stream 2 gas pipeline under Baltic Sea appears to have stopped leaking gas
UK train strikes and energy hikes add to a week of turmoil
Market Wizard who made $95 million for his clients in 2008 – and predicted the 2022 collapse back in January – reveals his strategy: (Ad)pixel
NIH to fund unproven ALS drugs under patient-backed law
Russia blindfolds, detains Ukraine nuclear plant chief
S&P 500   3,585.62
DOW   28,725.51
QQQ   267.26
Want to Increase Your Conversion Rates? This Is the Biggest Threat to Your Success.
Market Wizard who made $95 million for his clients in 2008 – and predicted the 2022 collapse back in January – reveals his strategy: (Ad)pixel
Russia accused of 'kidnapping' head of Ukraine nuclear plant
EU chief: New Greece-Bulgaria gas pipeline 'means freedom'
Market Wizard who made $95 million for his clients in 2008 – and predicted the 2022 collapse back in January – reveals his strategy: (Ad)pixel
Danish Energy Agency says Nord Stream 2 gas pipeline under Baltic Sea appears to have stopped leaking gas
UK train strikes and energy hikes add to a week of turmoil
Market Wizard who made $95 million for his clients in 2008 – and predicted the 2022 collapse back in January – reveals his strategy: (Ad)pixel
NIH to fund unproven ALS drugs under patient-backed law
Russia blindfolds, detains Ukraine nuclear plant chief
S&P 500   3,585.62
DOW   28,725.51
QQQ   267.26
Want to Increase Your Conversion Rates? This Is the Biggest Threat to Your Success.
Market Wizard who made $95 million for his clients in 2008 – and predicted the 2022 collapse back in January – reveals his strategy: (Ad)pixel
Russia accused of 'kidnapping' head of Ukraine nuclear plant
EU chief: New Greece-Bulgaria gas pipeline 'means freedom'
Market Wizard who made $95 million for his clients in 2008 – and predicted the 2022 collapse back in January – reveals his strategy: (Ad)pixel
Danish Energy Agency says Nord Stream 2 gas pipeline under Baltic Sea appears to have stopped leaking gas
UK train strikes and energy hikes add to a week of turmoil
Market Wizard who made $95 million for his clients in 2008 – and predicted the 2022 collapse back in January – reveals his strategy: (Ad)pixel
NIH to fund unproven ALS drugs under patient-backed law
Russia blindfolds, detains Ukraine nuclear plant chief
S&P 500   3,585.62
DOW   28,725.51
QQQ   267.26
Want to Increase Your Conversion Rates? This Is the Biggest Threat to Your Success.
Market Wizard who made $95 million for his clients in 2008 – and predicted the 2022 collapse back in January – reveals his strategy: (Ad)pixel
Russia accused of 'kidnapping' head of Ukraine nuclear plant
EU chief: New Greece-Bulgaria gas pipeline 'means freedom'
Market Wizard who made $95 million for his clients in 2008 – and predicted the 2022 collapse back in January – reveals his strategy: (Ad)pixel
Danish Energy Agency says Nord Stream 2 gas pipeline under Baltic Sea appears to have stopped leaking gas
UK train strikes and energy hikes add to a week of turmoil
Market Wizard who made $95 million for his clients in 2008 – and predicted the 2022 collapse back in January – reveals his strategy: (Ad)pixel
NIH to fund unproven ALS drugs under patient-backed law
Russia blindfolds, detains Ukraine nuclear plant chief
LON:FUM

Futura Medical - FUM Share Forecast, Price & News

GBX 37
+1.17 (+3.27%)
(As of 09/30/2022 12:00 AM ET)
Add
Compare
Today's Range
35.70
37
50-Day Range
28.60
46.85
52-Week Range
24
51.30
Volume
187,590 shs
Average Volume
401,769 shs
Market Capitalization
£106.30 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
FUM stock logo

About Futura Medical (LON:FUM) Stock

Futura Medical plc, a pharmaceutical company, develops pharmaceutical and healthcare products for the consumer healthcare markets focusing on sexual health and pain relief management. Its lead product is MED3000, a topical gel for the treatment of erectile dysfunction. The company also develops pain relief products, including TPR100, a topical diclofenac pain relief gel; CBD100, a topical cannabidiol formulation; and TIB200, a topical ibuprofen pain relief gel. The company was incorporated in 2001 and is headquartered in Guildford, the United Kingdom.

Receive FUM Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Futura Medical and its competitors with MarketBeat's FREE daily newsletter.

FUM Stock News Headlines

Futura Medical set for another period of key news flow
Will the Futura Medical share price run continue?
Judges Scientific makes earnings-enhancing acquisition
Futura Medical upgraded after Cooper Health deal
Futura Medical licenses ED treatment in Europe to Cooper
Arecor Therapeutics boosted by grant of US insulin patents
Futura Medical (LSE:FUM)
See More Headlines
Receive FUM Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Futura Medical and its competitors with MarketBeat's FREE daily newsletter.

FUM Company Calendar

Last Earnings
9/16/2020
Today
10/02/2022

Industry, Sector and Symbol

Industry
Drug Manufacturers - Major
Sub-Industry
N/A
Sector
Medical
CIK
N/A
Fax
N/A
Employees
13
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
£31,778.00
Cash Flow
GBX 2.38 per share
Book Value
GBX 2.60 per share

Miscellaneous

Free Float
N/A
Market Cap
£106.30 million
Optionable
Not Optionable
Beta
N/A

Key Executives

  • Mr. James Henry Barder (Age 62)
    CEO & Exec. Director
    Comp: $356.86k
  • Ms. Angela Hildreth
    COO, Fin. Director, Company Sec. & Exec. Director
  • Mr. Kenneth William James (Age 69)
    Head of R&D & Exec. Director
    Comp: $267.27k
  • Dr. William Duncan Potter (Age 74)
    Chief Scientific Officer & Adviser to the Board
  • Graham Smith
    Head of Alliance Partnerships & Supply
  • Kevin Langridge
    Head of Quality













FUM Stock - Frequently Asked Questions

How have FUM shares performed in 2022?

Futura Medical's stock was trading at GBX 39.30 on January 1st, 2022. Since then, FUM stock has decreased by 5.9% and is now trading at GBX 37.
View the best growth stocks for 2022 here
.

How were Futura Medical's earnings last quarter?

Futura Medical plc (LON:FUM) issued its quarterly earnings data on Wednesday, September, 16th. The company reported ($0.44) earnings per share for the quarter.

What other stocks do shareholders of Futura Medical own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Futura Medical investors own include Indivior (INDV), Tullow Oil (TLW), Bigblu Broadband (BBB), Directa Plus (DCTA), Genel Energy (GENL), Lakehouse (LAKE), Petrel Resources (PET), People's Operator (TPOP), CityFibre Infrastructure (CITY) and Paysafe Group (PAYS).

What is Futura Medical's stock symbol?

Futura Medical trades on the London Stock Exchange (LON) under the ticker symbol "FUM."

How do I buy shares of Futura Medical?

Shares of FUM stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
Compare Top Brokerages Here.

What is Futura Medical's stock price today?

One share of FUM stock can currently be purchased for approximately GBX 37.

How much money does Futura Medical make?

Futura Medical (LON:FUM) has a market capitalization of £106.30 million and generates £31,778.00 in revenue each year.

How can I contact Futura Medical?

Futura Medical's mailing address is 40 Surrey Technology Centre, Occam Road, GUILDFORD, GU2 7YG, United Kingdom. The official website for the company is www.futuramedical.com. The company can be reached via phone at +44-1483-685670.

This page (LON:FUM) was last updated on 10/2/2022 by MarketBeat.com Staff

MarketBeat Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | contact@marketbeat.com | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Privacy Policy | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see Barchart's disclaimer.